Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours
- PMID: 11748635
- DOI: 10.1002/path.1024
Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours
Abstract
Cancer is an epigenetic disease at the same level that it can be considered a genetic disease. In fact, epigenetic changes, particularly DNA methylation, are susceptible to change and are excellent candidates to explain how certain environmental factors may increase the risk of cancer. The delicate organization of methylation and chromatin states that regulates the normal cellular homeostasis of gene expression patterns becomes unrecognizable in the cancer cell. The genome of the transformed cell undergoes simultaneously a global genomic hypomethylation and a dense hypermethylation of the CpG islands associated with gene regulatory regions. These dramatic changes may lead to chromosomal instability, activation of endogenous parasitic sequences, loss of imprinting, illegitimate expression, aneuploidy, and mutations, and may contribute to the transcriptional silencing of tumour suppressor genes. The hypermethylation-associated inactivation affects virtually all of the pathways in the cellular network, such as DNA repair (hMLH1, BRCA1, MGMT, em leader), the cell cycle (p16(INK4a), p14(ARF), p15(INK4b), ...), and apoptosis (DAPK, APAF-1, ...). The aberrant CpG island methylation can also be used as a biomarker of malignant cells and as a predictor of their behaviour, and may constitute a good target for future therapies.
Copyright 2002 John Wiley & Sons, Ltd.
Similar articles
-
CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.Oncogene. 2002 Aug 12;21(35):5427-40. doi: 10.1038/sj.onc.1205600. Oncogene. 2002. PMID: 12154405 Review.
-
Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways.Br J Dermatol. 2006 Nov;155(5):999-1005. doi: 10.1111/j.1365-2133.2006.07487.x. Br J Dermatol. 2006. PMID: 17034532
-
A gene hypermethylation profile of human cancer.Cancer Res. 2001 Apr 15;61(8):3225-9. Cancer Res. 2001. PMID: 11309270
-
DNA methylation and gene silencing in cancer: which is the guilty party?Oncogene. 2002 Aug 12;21(35):5380-7. doi: 10.1038/sj.onc.1205598. Oncogene. 2002. PMID: 12154400 Review.
-
Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors.Cancer Res. 2002 Aug 1;62(15):4519-24. Cancer Res. 2002. PMID: 12154064
Cited by
-
Droplet digital PCR analysis of CDH13 methylation status in Slovak women with invasive ductal breast cancer.Sci Rep. 2024 Jun 26;14(1):14700. doi: 10.1038/s41598-024-65580-6. Sci Rep. 2024. PMID: 38926485 Free PMC article.
-
Nuclear DNA methylation and chromatin condensation phenotypes are distinct between normally proliferating/aging, rapidly growing/immortal, and senescent cells.Oncotarget. 2013 Mar;4(3):474-93. doi: 10.18632/oncotarget.942. Oncotarget. 2013. PMID: 23562889 Free PMC article.
-
Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.BMC Cancer. 2010 Jun 17;10:297. doi: 10.1186/1471-2407-10-297. BMC Cancer. 2010. PMID: 20565761 Free PMC article.
-
Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients.Oncogene. 2004 May 13;23(22):4014-22. doi: 10.1038/sj.onc.1207505. Oncogene. 2004. PMID: 15064737 Free PMC article.
-
Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development.Proc Natl Acad Sci U S A. 2007 Aug 7;104(32):13056-61. doi: 10.1073/pnas.0703739104. Epub 2007 Aug 1. Proc Natl Acad Sci U S A. 2007. PMID: 17670942 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
